Redhawk Wealth Advisors’s Meridian Bioscience Inc VIVO Stock Holding History

Redhawk Wealth Advisors’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-36,773	Closed	-$1.22M	–	216
2022 Q4	$1.22M	Sell	36,773 -1,125	-3%	-$36.2K	0.47%	59
2022 Q3	$1.2M	Buy	+37,898	New	+$1.23M	0.51%	47

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Redhawk Wealth Advisors's VIVO Position: Q1 2023 in Review

Redhawk Wealth Advisors sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 36,773 shares — an estimated $1.22M sold.

Redhawk Wealth Advisors first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $1.22M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Redhawk Wealth Advisors reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Redhawk Wealth Advisors sold 36,773 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.22M.
Redhawk Wealth Advisors first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
Redhawk Wealth Advisors's Meridian Bioscience Inc position peaked at $1.22M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Redhawk Wealth Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.